OMB Backs Away From Disputed Risk Assessment Policy
In an uncommon victory for the objectivity of the scientific advisory process, the Office of Management and Budget said that it would not implement a proposed new policy on regulatory risk assessments after a National Academy of Sciences panel said the policy was “fundamentally flawed.”
Last January the OMB issued a proposed “bulletin” (pdf) that prescribed new, centralized procedures for performing regulatory risk assessments.
But “the proposed definition of risk assessment in the OMB bulletin departs without justification from long-established concepts and practices,” the NAS panel said.
What’s worse, the proposed changes would mean that “agency risk assessments are more susceptible to being manipulated to achieve a predetermined result.”
Accordingly, the NAS panel recommended that the OMB bulletin be withdrawn. See this January 11 news release on the NAS report.
In light of the NAS critique, the OMB will not finalize the proposed bulletin, Rick Weiss of the Washington Post reported today.
See OMB Watch for further background on the OMB risk assessment proposal and the resulting controversy.
To secure the U.S. bio-infrastructure, maintain global leadership in biotechnology, and safeguard American citizens from emerging threats to their privacy, the federal government must modernize its approach to human genetic and biological data.
To ensure an energy transition that brings broad based economic development, participation, and direct benefits to communities, we need federal policy that helps shape markets. Unfortunately, there is a large gap in understanding of how to leverage federal policy making to support access to capital and credit.
From use to testing to deployment, the scaffolding for responsible integration of AI into high-risk use cases is just not there.
OPM’s new HR 2.0 initiative is entering hostile terrain. Those who have followed federal HR modernization for years desperately want this effort to succeed.